Short CommunicationCo-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment
-
Add time:10/01/2019 Source:sciencedirect.com
ObjectivesThis study aimed to describe the preparation and in vitro evaluation of a surface-modified nanostructured lipid carrier (NLC) using chitosan and dextran for co-delivery of buparvaquone (BPQ) and polymyxin B (PB) against leishmaniasis.
We also recommend Trading Suppliers and Manufacturers of Polymyxin B sulfate (cas 1405-20-5). Pls Click Website Link as below: cas 1405-20-5 suppliers
Prev:Short communicationStudy of interactions between carboxylated core shell magnetic nanoparticles and polymyxin B by capillary electrophoresis with inductively coupled plasma mass spectrometry
Next:Treatment of resistant visceral leishmaniasis with interferon gamma in combination with liposomal amphotericin B and allopurinol) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short communicationStudy of interactions between carboxylated core shell magnetic nanoparticles and polymyxin B by capillary electrophoresis with inductively coupled plasma mass spectrometry09/27/2019
- Binding interactions of bacterial lipopolysaccharides to polymyxin B in an amphiphilic carrier ‘sodium deoxycholate sulfate’09/26/2019
- Antimicrobial gelatin-based elastomer nanocomposite membrane loaded with ciprofloxacin and Polymyxin B sulfate (cas 1405-20-5) in halloysite nanotubes for wound dressing09/25/2019
- Enhanced Rhodococcus pyridinivorans sp. strain HR-1 anode performance in microbial fuel cells by adding Polymyxin B sulfate (cas 1405-20-5)09/24/2019
-
Health and Chemical more >